Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001300836 | SCV001489986 | uncertain significance | Nephronophthisis 9 | 2022-08-15 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the NEK8 mRNA. It is expected to extend the length of the NEK8 protein by 10 additional amino acid residues. This variant is present in population databases (rs746234904, gnomAD 0.01%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 1004174). This variant has not been reported in the literature in individuals affected with NEK8-related conditions. |
Fulgent Genetics, |
RCV002476394 | SCV002791890 | uncertain significance | Nephronophthisis 9; Renal-hepatic-pancreatic dysplasia 2 | 2022-04-30 | criteria provided, single submitter | clinical testing |